Overview

Full Product Details

Author:   Robert Haim Belmaker ,  Pesach Lichtenberg
Publisher:   Springer International Publishing AG
Imprint:   Springer International Publishing AG
Edition:   1st ed. 2023
Weight:   0.567kg
ISBN:  

9783031403705

ISBN 10:   3031403703
Pages:   220
Publication Date:   19 October 2023
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Biochemical basis for psychopharmacology in the brain synapse.-Are DSM or ICD diagnoses the basis for scientific use of psychopharmacologic drugs.-The clinical control trial: What it is, what is has been and does it have a future?.-Antidepressant drugs: For anyone sad or only for the melancholic depressed?.-Antipsychotic drugs: Do they define schizophrenia or do they depress all emotions?.-Antianxiety medications: Are they addictive or are they mankind’s precious heritage?.-Mood stabilizers: Is lithium the gold standard?.-Electroconvulsive therapy, transcranial magnetic stimulation and deep brain stimulation.-Addictive substances and pain medication.-Stimulant drugs: Are they specific for attention deficit disorder and are they abused and overused?.-Drugs for Alzheimer’s and other dementia: Are they worth anything?.-Drugs for obsessive compulsive disorder: could such obviously psychological disorders have a pharmacological treatment?.-Cannabis:  A Useful Psychotropic?.-The placeboresponse in psychopharmacology and the use of nutraceuticals in clinical psychiatry.-Chapter 15: Is there a potential for new treatments in psychopharmacology or have we picked all the low hanging fruit?

Reviews

Author Information

Robert Haim Belmaker, Division of  Psychiatry, Ben-Gurion University of the Negev, Israel. belmaker@bgu.ac.il Prof. Robert Haim Belmaker is an Israeli psychiatrist who has had major academic positions in Israeli psychiatry since 1974. He had a formative influence on biological directions in Israeli psychiatry. He was Professor of Psychiatry at Ben-Gurion University of the Negev, Beersheva Israel and is now Emeritus. He was President of the International College of Neuropsychopharmacology 2008–2010, Vice President of the International Society for Bipolar Disorders 2012-2014, President of the Israel Psychiatry Association 2015–2018 and is Fellow Emeritus of  the American College of Neuropsychopharmacology.   He has co-edited 18 books in psychopharmacology and authored over 400 original papers.    Pesach Lichtenberg, M.D., The Hebrew University in Jerusalem; Soteria Israel; and the Jerusalem Mental Health Center. pesach.lichtenberg@mail.huji.ac.il Prof. Pesach Lichtenberg has directed acute care psychiatric wards for 25 years, currently in the Jerusalem Mental Health Center. He served as the Academic Chair of Psychiatry at the Faculty of Medicine of the Hebrew University in Jerusalem. His academic work has covered psychopharmacology, diagnosis, hypnosis and placebo. His clinical and research activity in recent years focuses on the Soteria  model for psychosis, which he brought to Israel, and which has catalyzed far-reaching changes in the public mental health care system.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions